Author
Number of items: 53.
2017
Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus. (2017)
Satyajit S Shetage,
Matthew J Traynor,
Marc B Brown,
Thomas M Galliford
and
Robert P Chilcott
![]()
The percutaneous toxicokinetics of sulphur mustard in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant. (2017)
Charlotte Hall,
Helen Lydon,
Christopher Dalton,
J. Kevin Chipman,
John Graham
and
Robert Chilcott
![]()
Hair analysis for the detection of drug use – is there potential for evasion? (2017)
Shanna Marrinan,
Andres Roman-Urrestarazu,
Declan Naughton,
Emerlinda Levari,
John Collins,
Robert Chilcott,
Giuseppe Bersani
and
Ornella Corazza
![]()
Volunteer trials of a novel improvised dry decontamination protocol for use during mass casualty incidents as part of the UK’S Initial Operational Response (IOR). (2017)
Richard Amlôt,
Holly Carter,
Lorna Riddle,
Joanne Larner
and
Robert P. Chilcott
![]()
Development of haemostatic decontaminants for treatment of wounds contaminated with chemical warfare agents. 3: Evaluation of in vitro topical decontamination efficacy using damaged skin. (2017)
Helen L. Lydon,
Charlotte A. Hall,
Christopher H. Dalton,
J. Kevin Chipman,
John S. Graham
and
Robert Chilcott
![]()
Captagon: Use and Trade in the Middle East. (2017)
Ahmed Al-Imam,
Rita Santacroce,
Andres Roman-Urrestarazu,
Robert Chilcott,
G. Martinotti,
Giuseppe Bersani
and
Ornella Corazza
![]()
Evaluation of absorbent materials for use as ad hoc dry decontaminants during mass casualty incidents as part of the UK’s Initial Operational Response (IOR). (2017)
Robert Chilcott,
Nick Kassouf,
Sara Syed,
Joanne Larner
and
Richard Amlôt
![]()
2016
Mass Casualty Decontamination in the United States : An Online Survey of Current Practice. (2016)
Sarah Power,
Charles Symons,
Holly Carter,
Emma Jones,
Richard Amlôt,
Joanne Larner,
Hazem Matar
and
Robert P Chilcott
![]()
Preliminary evaluation of military, commercial and novel skin decontamination products against a chemical warfare agent simulant (methyl salicylate). (2016)
Hazem Matar,
Antonio Guerreiro,
Sergey A. Piletsky,
Shirley Price
and
Robert Chilcott
![]()
2015
Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 2 : Evaluation of in vitro topical decontamination efficacy using undamaged skin. (2015)
Christopher H. Dalton,
Charlotte A. Hall,
Helen L. Lydon,
J. Kevin Chipman,
John S. Graham,
John Jenner
and
Robert Chilcott
Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1 : Evaluation of in vitro clotting efficacy in the presence of certain contaminants. (2015)
Charlotte A. Hall,
Helen L. Lydon,
Christopher H. Dalton,
J. Kevin Chipman,
John S. Graham
and
Robert Chilcott
Development of a cumulative irritation model for incontinence-associated dermatitis. (2015)
J. Larner,
H. Matar,
V. S. Goldman
and
Robert Chilcott
Optimisation of a dosing regime for a topical skin protectant (barrier cream). (2015)
Robert Chilcott,
Joanne Larner,
Hazem Matar,
Sneha Kansagra,
Baveetharan Theivendran,
Vanessa Ann Viegas
and
Virginia Streusand Goldman
2014
Managing mass casualties and decontamination. (2014)
Robert Chilcott
Recent advances to address European Union Health Security from cross border chemical health threats. (2014)
R. Duarte-Davidson,
R. Orford,
S. Wyke,
M. Griffiths,
R. Amlôt
and
Robert Chilcott
Design and characterisation of a novel in vitro skin diffusion cell system for assessing mass casualty decontamination systems. (2014)
H. Matar,
J. Larner,
S. Kansagra,
K. L. Atkinson,
J. T. Skamarauskas,
R. Amlot
and
Robert Chilcott
Collection and characterisation of residual skin surface components obtained from sebum, sweat and epidermal lipids. (2014)
S.S. Shetage,
M.J. Traynor,
Marc Brown
and
Robert Chilcott
Section Editorial - Cosmeceuticals. (2014)
R. P. Chilcott
Section editorial - Regulatory and toxicology. (2014)
R. P. Chilcott
Effect of ethnicity, gender and age on the amount and composition of residual skin surface components derived from sebum, sweat and epidermal lipids. (2014)
Satyajit Shetage,
M.J. Traynor,
Marc Brown,
Mahad Raji,
Diepiriyie Graham-Kalio
and
Robert Chilcott
![]()
2012
In vivo decontamination of the nerve agent VX using the domestic swine model. (2012)
Jan Misik,
Michal Pavlik,
Ladislav Novotny,
Ruzena Pavlikova,
Robert Chilcott,
Jiri Cabal
and
Kamil Kuca
Variations in residual skin surface components based on age, gender and ethnicity. (2012)
S. S. Shetage,
Marc Brown,
Robert Chilcott
and
M.J. Traynor
Pharmacokinetics of acetylcholinesterase reactivator K203 and consequent evaluation of low molecular weight antioxidants/markers of oxidative stress. (2012)
J.Z. Karasová,
D. Hnídková,
M. Pohanka,
K. Musílek,
K. Kuča
and
Robert Chilcott
2009
Whole-body imaging of UV-fluorescent chemical warfare simulants: A potentially quantitative technique for the optimisation of mass casualty decontamination procedures. (2009)
Joanne Larner,
Hazem Matar,
David R. Jones,
Richard Amlot,
Holly Carter,
Elizabeth A. Turner,
Shirley C. Price
and
Robert Chilcott
The in vitro efficacy of haemostatic products in the presence of chemical warfare agents-Sulphur mustard (HD) and VX. (2009)
Charlotte A. Hall,
Helen L. Lydon,
Christopher H. Dalton,
J. Kevin Chipman,
Robert Chilcott
and
John S. Graham
2005
Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig. (2005)
Robert Chilcott,
C. H. Dalton,
I. Hill,
C. M. Davison,
K. L. Blohm,
E. D. Clarkson
and
M. G. Hamilton
In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig. (2005)
Robert Chilcott,
C. H. Dalton,
I. Hill,
C. M. Davison,
K. L. Blohm,
E. D. Clarkson
and
M. G. Hamilton
Toxicity of sulphur mustard. (2005)
Robert Chilcott
Inter- and intralaboratory variation of in vitro diffusion cell measurements : An international multicenter study using quasi-standardized methods and materials. (2005)
Robert Chilcott,
N Barai,
A. E. Beezer,
S I Brain,
Marc Brown,
A L Bunge,
S E Burgess,
S Cross,
C H Dalton,
M Dias,
A Farinha,
B C Finnin,
S J Gallagher,
D M Green,
H Gunt,
R L Gwyther,
C.M. Heard,
C A Jarvis,
F Kamiyama,
G B Kasting,
E E Ley,
S T Lim,
G S Mcnaughton,
A Morris,
M H Nazemi,
M A Pellett,
J Du Plessis,
Y S Quan,
S L Raghavan,
M. Roberts,
W Romonchuk,
C S Roper,
D Schenk,
L Simonsen,
A Simpson,
B D Traversa,
L Trottet,
A Watkinson,
F.M. Williams,
S C Wilkinson,
A Yamamoto
and
J. Hadgraft
2000
The electrostability and electrically assisted delivery of an organophosphate pretreatment (physostigmine) across human skin in vitro. (2000)
C. A. Rowland
and
Robert Chilcott
Biophysical measurements of human forearm, skin in vivo : effects of site, gender, chirality and time. (2000)
Robert Chilcott
and
R. Farrar
Non-invasive quantification of skin injury resulting from exposure to sulphur mustard and Lewisite vapours. (2000)
Robert Chilcott,
Roger F. R. Brown
and
P Rice
Dermabrasion - a novel concept in the surgical management of sulphur mustard injuries. (2000)
P. Rice,
Roger F. R. Brown,
D. G. K. Lam,
Robert Chilcott
and
N. J. Bennett
Human skin absorption of bis-2-(chloroethyl)sulphide (sulphur mustard) in vitro. (2000)
Robert Chilcott,
J. Jenner,
W. Carrick,
S. A. M. Hotchkiss
and
P. Rice